Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the reliability of a new non-invasive device to assess the blood coagulation status among term and preterm babies.


Clinical Trial Description

Coagulation abnormalities among neonates aren't common - but can be life threatening. Testing the coagulation system in small babies involves drawing significant amounts of blood (especially in premature babies). Non-invasive testing can help assess and treat term and preterm neonates at risk. Recently, a non-invasive device to assess the blood coagulation status was developed - The Thrombo-Monitor (ThM). The objective of this study is to assess the reliability of this new non-invasive device among term and preterm babies by comparing the result of the ThM reading to coagulation analysis from blood. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01167660
Study type Observational
Source Meir Medical Center
Contact Ita Litmanovitz, MD
Phone +972-9-7471554
Email litmani@clalit.org.il
Status Recruiting
Phase N/A
Start date July 2010
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03647254 - Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study) N/A
Unknown status NCT02255214 - Evaluation of the Accuracy of the Hemochron Signature Elite Point of Care Device Compared With Laboratory Assay N/A
Completed NCT01588327 - A Prospective Pharmacodynamic Study of Dabigatran N/A
Completed NCT03280368 - Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
Terminated NCT02839434 - Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy